SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3e02'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OE2_A_CUA502_0 (DISSIMILATORY COPPER-CONTAINING NITRITE REDUCTASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	3 / 3	GLU A 258 HIS A 49 HIS A 51	ZN A 311 (-2.5A) ZN A 311 (-3.3A) ZN A 311 (-3.4A)	0.65A	1oe2A-3e02A: undetectable	1oe2A-3e02A: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SKX_A_RFPA1_2 (ORPHAN NUCLEAR RECEPTOR PXR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 5	PHE A 151 LEU A 94 MET A 158 LEU A 196	None EDO A 320 (-4.5A) None None	1.16A	1skxA-3e02A: undetectable	1skxA-3e02A: 22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JC9_A_ADNA1497_1 (CYTOSOLIC PURINE 5'-NUCLEOTIDASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 7	ASP A 294 THR A 292 ILE A 8 ASN A 252	None	1.26A	2jc9A-3e02A: undetectable	2jc9A-3e02A: 20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.13A	2yjaB-3e02A: undetectable	2yjaB-3e02A: 23.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A2Q_A_ACAA601_1 (6-AMINOHEXANOATE-CYC LIC-DIMER HYDROLASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 7	GLY A 37 ALA A 45 ALA A 80 VAL A 276	None	0.74A	3a2qA-3e02A: undetectable	3a2qA-3e02A: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DLC_A_SAMA220_0 (PUTATIVE S-ADENOSYL-L-METHION INE-DEPENDENT METHYLTRANSFERASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	PHE A 118 GLY A 89 GLY A 91 HIS A 49 SER A 16	EDO A 313 (-4.9A) None EDO A 317 ( 3.9A) ZN A 311 (-3.3A) None	1.15A	3dlcA-3e02A: undetectable	3dlcA-3e02A: 22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_A_ROFA901_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	3 / 3	ASP A 63 LEU A 66 GLN A 73	None	0.76A	3g4lA-3e02A: undetectable	3g4lA-3e02A: 20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_J_TFPJ201_1 (PROTEIN S100-A4)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 8	PHE A 151 PHE A 184 CYH A 172 MET A 113	None	1.07A	3ko0B-3e02A: undetectable 3ko0J-3e02A: undetectable	3ko0B-3e02A: 15.89 3ko0J-3e02A: 15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OKX_A_SAMA201_0 (YAEB-LIKE PROTEIN RPA0152)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	LEU A 196 CYH A 172 TYR A 179 LEU A 223 LEU A 181	None	1.17A	3okxA-3e02A: undetectable	3okxA-3e02A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OKX_A_SAMA201_0 (YAEB-LIKE PROTEIN RPA0152)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	LEU A 196 HIS A 215 TYR A 179 LEU A 223 LEU A 181	None	1.28A	3okxA-3e02A: undetectable	3okxA-3e02A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OKX_B_SAMB201_1 (YAEB-LIKE PROTEIN RPA0152)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	LEU A 196 CYH A 172 TYR A 179 LEU A 223 LEU A 181	None	1.18A	3okxB-3e02A: undetectable	3okxB-3e02A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OKX_B_SAMB201_1 (YAEB-LIKE PROTEIN RPA0152)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	LEU A 196 HIS A 215 TYR A 179 LEU A 223 LEU A 181	None	1.33A	3okxB-3e02A: undetectable	3okxB-3e02A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OLS_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.12A	3olsA-3e02A: undetectable	3olsA-3e02A: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.10A	3q95A-3e02A: undetectable	3q95A-3e02A: 23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UUD_A_ESTA600_1 (ESTROGEN RECEPTOR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 11	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.12A	3uudA-3e02A: undetectable	3uudA-3e02A: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VLN_A_ACTA908_0 (GLUTATHIONE S-TRANSFERASE OMEGA-1)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 4	MET A 245 SER A 246 LEU A 213 VAL A 232	None	1.29A	3vlnA-3e02A: 0.0	3vlnA-3e02A: 23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B7Q_A_ZMRA601_2 (NEURAMINIDASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	3 / 3	ARG A 280 ARG A 277 ILE A 290	None EDO A 321 (-4.2A) None	0.80A	4b7qA-3e02A: undetectable	4b7qA-3e02A: 21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B7Q_A_ZMRA601_2 (NEURAMINIDASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	3 / 3	ARG A 280 ARG A 281 ILE A 290	None EDO A 321 (-3.1A) None	0.91A	4b7qA-3e02A: undetectable	4b7qA-3e02A: 21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B7Q_C_ZMRC601_2 (NEURAMINIDASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	3 / 3	ARG A 280 ARG A 277 ILE A 290	None EDO A 321 (-4.2A) None	0.84A	4b7qC-3e02A: undetectable	4b7qC-3e02A: 21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 12	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.10A	4pxmA-3e02A: undetectable	4pxmA-3e02A: 23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZZ8_A_GCSA208_1 (GLUCANASE/CHITOSANAS E)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 7	GLU A 36 GLU A 274 ALA A 269 TYR A 25	EDO A 316 ( 4.7A) EDO A 312 (-4.6A) None None	0.90A	4zz8A-3e02A: undetectable	4zz8A-3e02A: 17.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXB_B_ESTB601_1 (ESTROGEN RECEPTOR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 11	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.13A	5dxbB-3e02A: undetectable	5dxbB-3e02A: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXG_B_ESTB601_1 (ESTROGEN RECEPTOR)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	5 / 11	ALA A 99 LEU A 94 ARG A 156 GLY A 89 HIS A 51	None EDO A 320 (-4.5A) EDO A 320 (-4.5A) None ZN A 311 (-3.4A)	1.11A	5dxgB-3e02A: undetectable	5dxgB-3e02A: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_S_BEZS801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 6	SER A 16 HIS A 51 MET A 92 LEU A 147	None ZN A 311 (-3.4A) None None	1.18A	5dzke-3e02A: 2.8 5dzks-3e02A: undetectable	5dzke-3e02A: 23.32 5dzks-3e02A: 0.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_B_PCFB1802_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 7	SER A 164 THR A 166 PHE A 168 VAL A 108	None	1.09A	5vkqA-3e02A: undetectable 5vkqB-3e02A: undetectable	5vkqA-3e02A: 11.01 5vkqB-3e02A: 11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_C_PCFC1803_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 8	SER A 164 THR A 166 PHE A 168 VAL A 108	None	1.07A	5vkqB-3e02A: undetectable 5vkqC-3e02A: undetectable	5vkqB-3e02A: 11.01 5vkqC-3e02A: 11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_D_PCFD1803_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 7	SER A 164 THR A 166 PHE A 168 VAL A 108	None	1.09A	5vkqC-3e02A: undetectable 5vkqD-3e02A: undetectable	5vkqC-3e02A: 11.01 5vkqD-3e02A: 11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 5	ARG A 156 MET A 158 THR A 159 LEU A 189	EDO A 320 (-4.5A) None None None	1.15A	5z86J-3e02A: undetectable	5z86J-3e02A: 10.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GTQ_B_ACTB207_0 (DUF1778 DOMAIN-CONTAINING PROTEIN N-ACETYLTRANSFERASE)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 6	LEU A 26 THR A 14 GLY A 15 ARG A 53	None None ZN A 311 ( 4.8A) None	1.30A	6gtqB-3e02A: 0.0 6gtqD-3e02A: undetectable	6gtqB-3e02A: 21.54 6gtqD-3e02A: 9.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_W_CHDW102_0 (CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3e02	UNCHARACTERIZED PROTEIN DUF849 (Paraburkholderia xenovorans)	4 / 5	ARG A 156 MET A 158 THR A 159 LEU A 189	EDO A 320 (-4.5A) None None None	1.36A	6nknW-3e02A: undetectable	6nknW-3e02A: 10.93

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1OE2_A_CUA502_0","DISSIMILATORY COPPER-CONTAINING NITRITE REDUCTASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",3,"GLU A 258;HIS A  49;HIS A  51"," ZN A 311 (-2.5A); ZN A 311 (-3.3A); ZN A 311 (-3.4A)","0.65A","1oe2A-3e02A:undetectable","1oe2A-3e02A:21.12"],["1SKX_A_RFPA1_2","ORPHAN NUCLEAR RECEPTOR PXR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"PHE A 151;LEU A  94;MET A 158;LEU A 196","None;EDO A 320 (-4.5A);None;None","1.16A","1skxA-3e02A:undetectable","1skxA-3e02A:22.38"],["2JC9_A_ADNA1497_1","CYTOSOLIC PURINE 5'-NUCLEOTIDASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"ASP A 294;THR A 292;ILE A   8;ASN A 252","None","1.26A","2jc9A-3e02A:undetectable","2jc9A-3e02A:20.99"],["2YJA_B_ESTB1550_1","ESTROGEN RECEPTOR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.13A","2yjaB-3e02A:undetectable","2yjaB-3e02A:23.30"],["3A2Q_A_ACAA601_1","6-AMINOHEXANOATE-CYCLIC-DIMER HYDROLASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"GLY A  37;ALA A  45;ALA A  80;VAL A 276","None","0.74A","3a2qA-3e02A:undetectable","3a2qA-3e02A:20.24"],["3DLC_A_SAMA220_0","PUTATIVE S-ADENOSYL-L-METHIONINE-DEPENDENT METHYLTRANSFERASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"PHE A 118;GLY A  89;GLY A  91;HIS A  49;SER A  16","EDO A 313 (-4.9A);None;EDO A 317 ( 3.9A); ZN A 311 (-3.3A);None","1.15A","3dlcA-3e02A:undetectable","3dlcA-3e02A:22.19"],["3G4L_A_ROFA901_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",3,"ASP A  63;LEU A  66;GLN A  73","None","0.76A","3g4lA-3e02A:undetectable","3g4lA-3e02A:20.53"],["3KO0_J_TFPJ201_1","PROTEIN S100-A4;PROTEIN S100-A4","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"PHE A 151;PHE A 184;CYH A 172;MET A 113","None","1.07A","3ko0B-3e02A:undetectable;3ko0J-3e02A:undetectable","3ko0B-3e02A:15.89;3ko0J-3e02A:15.89"],["3OKX_A_SAMA201_0","YAEB-LIKE PROTEIN RPA0152","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"LEU A 196;CYH A 172;TYR A 179;LEU A 223;LEU A 181","None","1.17A","3okxA-3e02A:undetectable","3okxA-3e02A:20.87"],["3OKX_A_SAMA201_0","YAEB-LIKE PROTEIN RPA0152","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"LEU A 196;HIS A 215;TYR A 179;LEU A 223;LEU A 181","None","1.28A","3okxA-3e02A:undetectable","3okxA-3e02A:20.87"],["3OKX_B_SAMB201_1","YAEB-LIKE PROTEIN RPA0152","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"LEU A 196;CYH A 172;TYR A 179;LEU A 223;LEU A 181","None","1.18A","3okxB-3e02A:undetectable","3okxB-3e02A:20.87"],["3OKX_B_SAMB201_1","YAEB-LIKE PROTEIN RPA0152","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"LEU A 196;HIS A 215;TYR A 179;LEU A 223;LEU A 181","None","1.33A","3okxB-3e02A:undetectable","3okxB-3e02A:20.87"],["3OLS_A_ESTA600_1","ESTROGEN RECEPTOR BETA","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.12A","3olsA-3e02A:undetectable","3olsA-3e02A:21.88"],["3Q95_A_ESLA700_1","ESTROGEN RECEPTOR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.10A","3q95A-3e02A:undetectable","3q95A-3e02A:23.82"],["3UUD_A_ESTA600_1","ESTROGEN RECEPTOR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.12A","3uudA-3e02A:undetectable","3uudA-3e02A:23.26"],["3VLN_A_ACTA908_0","GLUTATHIONE S-TRANSFERASE OMEGA-1","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"MET A 245;SER A 246;LEU A 213;VAL A 232","None","1.29A","3vlnA-3e02A:0.0","3vlnA-3e02A:23.27"],["4B7Q_A_ZMRA601_2","NEURAMINIDASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",3,"ARG A 280;ARG A 277;ILE A 290","None;EDO A 321 (-4.2A);None","0.80A","4b7qA-3e02A:undetectable","4b7qA-3e02A:21.92"],["4B7Q_A_ZMRA601_2","NEURAMINIDASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",3,"ARG A 280;ARG A 281;ILE A 290","None;EDO A 321 (-3.1A);None","0.91A","4b7qA-3e02A:undetectable","4b7qA-3e02A:21.92"],["4B7Q_C_ZMRC601_2","NEURAMINIDASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",3,"ARG A 280;ARG A 277;ILE A 290","None;EDO A 321 (-4.2A);None","0.84A","4b7qC-3e02A:undetectable","4b7qC-3e02A:21.92"],["4PXM_A_ESTA2000_1","ESTROGEN RECEPTOR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.10A","4pxmA-3e02A:undetectable","4pxmA-3e02A:23.85"],["4ZZ8_A_GCSA208_1","GLUCANASE\/CHITOSANASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"GLU A  36;GLU A 274;ALA A 269;TYR A  25","EDO A 316 ( 4.7A);EDO A 312 (-4.6A);None;None","0.90A","4zz8A-3e02A:undetectable","4zz8A-3e02A:17.10"],["5DXB_B_ESTB601_1","ESTROGEN RECEPTOR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.13A","5dxbB-3e02A:undetectable","5dxbB-3e02A:24.05"],["5DXG_B_ESTB601_1","ESTROGEN RECEPTOR","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",5,"ALA A  99;LEU A  94;ARG A 156;GLY A  89;HIS A  51","None;EDO A 320 (-4.5A);EDO A 320 (-4.5A);None; ZN A 311 (-3.4A)","1.11A","5dxgB-3e02A:undetectable","5dxgB-3e02A:24.05"],["5DZK_S_BEZS801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"SER A  16;HIS A  51;MET A  92;LEU A 147","None; ZN A 311 (-3.4A);None;None","1.18A","5dzke-3e02A:2.8;5dzks-3e02A:undetectable","5dzke-3e02A:23.32;5dzks-3e02A:0.93"],["5VKQ_B_PCFB1802_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"SER A 164;THR A 166;PHE A 168;VAL A 108","None","1.09A","5vkqA-3e02A:undetectable;5vkqB-3e02A:undetectable","5vkqA-3e02A:11.01;5vkqB-3e02A:11.01"],["5VKQ_C_PCFC1803_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"SER A 164;THR A 166;PHE A 168;VAL A 108","None","1.07A","5vkqB-3e02A:undetectable;5vkqC-3e02A:undetectable","5vkqB-3e02A:11.01;5vkqC-3e02A:11.01"],["5VKQ_D_PCFD1803_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"SER A 164;THR A 166;PHE A 168;VAL A 108","None","1.09A","5vkqC-3e02A:undetectable;5vkqD-3e02A:undetectable","5vkqC-3e02A:11.01;5vkqD-3e02A:11.01"],["5Z86_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"ARG A 156;MET A 158;THR A 159;LEU A 189","EDO A 320 (-4.5A);None;None;None","1.15A","5z86J-3e02A:undetectable","5z86J-3e02A:10.93"],["6GTQ_B_ACTB207_0","DUF1778 DOMAIN-CONTAINING PROTEIN;N-ACETYLTRANSFERASE","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"LEU A  26;THR A  14;GLY A  15;ARG A  53","None;None; ZN A 311 ( 4.8A);None","1.30A","6gtqB-3e02A:0.0;6gtqD-3e02A:undetectable","6gtqB-3e02A:21.54;6gtqD-3e02A:9.70"],["6NKN_W_CHDW102_0","CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3e02","UNCHARACTERIZED PROTEIN DUF849","Paraburkholderia xenovorans",4,"ARG A 156;MET A 158;THR A 159;LEU A 189","EDO A 320 (-4.5A);None;None;None","1.36A","6nknW-3e02A:undetectable","6nknW-3e02A:10.93"]]